Policy

A recent proposal from the Trump administration to force hospitals to publish their negotiated rates with insurers is facing a new legal challenge, according to Bloomberg Law.

CMS is planning to add a star ratings system to insurance plans offered through the individual exchange created from the Affordable Care Act, the agency announced August 15. The new ratings will be displayed for the 2020 open enrollment period on Healthcare.gov.

Illinois became the first state to require insurance companies to pay the costs of EpiPen injection medicines for children 18 and younger.

Drugmakers, wanting to develop new products informed by disease insights, are snapping up genetic profiles of hospital patients and spending hundreds of millions of dollars to get the data. But the practice is throwing into question who should control this “valuable genetic data."

Out-of-network billing in emergency departments has risen over the last few years, often leaving patients with surprise expenses even when they have insurance coverage and receive care from an in-network hospital.

HHS has awarded $400 million through the Health Resources and Services Administration (HRSA) to fund community health centers, rural organizations and academic institutions to develop and expand services to combat the opioid abuse crisis.

CMS has decided to cover an expensive and new therapy that uses a patient’s own genetically modified immune cells to treat cancer.

Medical schools are facing pressure from doctors, industry organizations and students to add climate change to the curriculum, The Wall Street Journal reported.

 

The Trump administration is working on a new healthcare plan that can act as an alternative to Medicare for all, which has been adopted in the platforms of several Democratic presidential candidates. The administration is contemplating releasing their plan in September.

The drug industry is not happy about a new plan from the Trump administration that would allow cheaper drugs to be imported from Canada. The initiative, called the Safe Importation Action Plan, was announced by HHS July 31.

In the second round of presidential debate of Democratic candidates, the hopefuls took on healthcare right away, debating Medicare-for-all proposals and a public option on stage. The arguments over healthcare “set a combative tone” for the rest of the debate.

HHS is launching a new action plan for the safe importation of certain prescription drugs to bring in medications from foreign markets. The Safe Importation Action Plan extends recent initiatives from the Trump administration to make prescription drugs cheaper in the U.S.